Today: 20 March 2026
Subscribe
Browse Category

Stock Market 24 December 2025

Salesforce (CRM) Stock News Today: Agentforce Momentum, AI Reliability Questions, and Updated Wall Street Forecasts (Dec. 24, 2025)

Salesforce (CRM) Stock News Today: Agentforce Momentum, AI Reliability Questions, and Updated Wall Street Forecasts (Dec. 24, 2025)

Salesforce shares traded near $266 at midday Dec. 24, up slightly, but remain down about 21% for 2025 after a volatile year. Q3 FY2026 results showed revenue of $10.3 billion, up 9% year-over-year, and a non-GAAP operating margin of 35.5%. The company raised its full-year revenue guidance to $41.45–$41.55 billion. Investors are watching adoption of Agentforce and Data 360 amid debate over AI reliability.
24 December 2025
··
Wave Life Sciences (WVE) Stock: December 24, 2025 News Roundup, Analyst Forecasts, and What Investors Are Watching Next

Wave Life Sciences (WVE) Stock: December 24, 2025 News Roundup, Analyst Forecasts, and What Investors Are Watching Next

Wave Life Sciences shares traded around $18.1–$18.5 on December 24, 2025, holding gains after positive WVE-007 obesity data and a recent capital raise. No new company news crossed the wire, but analysts raised fair value targets following the Phase 1 results showing reduced visceral fat and increased lean mass. At least one after-hours trade printed below the regular close amid thin holiday volume.
24 December 2025
··
Intel Stock INTC Slips as Nvidia Pauses 18A Test: Latest News, Forecasts, and What Matters Next

Intel Stock INTC Slips as Nvidia Pauses 18A Test: Latest News, Forecasts, and What Matters Next

Intel shares fell about 1% to $35.97 on December 24 after reports that Nvidia halted testing of Intel’s 18A chip manufacturing process. Trading was light in a shortened Christmas Eve session. Intel said its 18A technology is progressing and highlighted ongoing interest in its next-generation 14A process. The U.S. government recently announced an $8.9 billion equity investment in Intel.
24 December 2025
·
Travere Therapeutics (TVTX) Stock Jumps on Dec. 24, 2025: 52-Week High, FDA Catalyst Ahead, and Analyst Price Targets

Travere Therapeutics (TVTX) Stock Jumps on Dec. 24, 2025: 52-Week High, FDA Catalyst Ahead, and Analyst Price Targets

Travere Therapeutics shares jumped about 15% to over $40 in early trading on Dec. 24, 2025, hitting new highs during a holiday-shortened session. The surge followed investor anticipation of an FDA decision on FILSPARI for FSGS, expected by Jan. 13, 2026. No company news was released that day. The FDA previously waived an advisory committee review for the application.
24 December 2025
·
Nike Stock (NKE) Jumps on Tim Cook’s $3M Share Buy as Turnaround Pressures Mount: News, Forecasts and Analysis for Dec. 24, 2025

Nike Stock (NKE) Jumps on Tim Cook’s $3M Share Buy as Turnaround Pressures Mount: News, Forecasts and Analysis for Dec. 24, 2025

Nike shares jumped about 5% to $60 in a shortened Christmas Eve session after filings showed Apple CEO Tim Cook bought 50,000 shares, nearly doubling his stake. The $3 million open-market purchase, disclosed Wednesday, came after Nike stock had dropped 13% following disappointing guidance and margin concerns. Another director, Robert Swan, also bought shares.
24 December 2025
··
Home Depot Stock (HD) News Today, Dec. 24, 2025: Price Action, Analyst Forecasts, and What Investors Are Watching

Home Depot Stock (HD) News Today, Dec. 24, 2025: Price Action, Analyst Forecasts, and What Investors Are Watching

Home Depot shares rose 0.7% to $347.51 in light trading during a shortened Christmas Eve session. Wall Street analysts maintained a “Buy” consensus, but earnings estimate revisions turned slightly negative. The Schall Law Firm announced a new fraud investigation tied to Home Depot’s Q3 2025 results. The S&P 500 hit a record intraday high as broader market sentiment improved.
24 December 2025
·
Procter & Gamble (PG) Stock Today: Analyst Upgrades, Tariff Pressures, and a CEO Change Set the Tone for 2026

Procter & Gamble (PG) Stock Today: Analyst Upgrades, Tariff Pressures, and a CEO Change Set the Tone for 2026

Procter & Gamble shares traded near $144.70 on December 24, rebounding slightly after hitting a yearly low of $138.14 earlier in December. The stock is down about 12% year-to-date. A CEO transition is set for January 1, with Shailesh Jejurikar replacing Jon Moeller. The company plans to cut 7,000 non-manufacturing jobs and exit some product categories.
24 December 2025
·
Polestar Stock (PSNY) Surges on Fresh Funding: Latest News, Analyst Forecasts, and What Investors Are Watching (Dec. 24, 2025)

Polestar Stock (PSNY) Surges on Fresh Funding: Latest News, Analyst Forecasts, and What Investors Are Watching (Dec. 24, 2025)

Polestar shares surged about 13% to $17.09 on December 24, 2025, after announcing a $300 million equity investment from BBVA and Natixis, plus a $300 million debt-to-equity conversion with Geely. Trading volume topped 200,000 shares. The moves aim to boost liquidity and address debt concerns as the company faces EV market pressures.
24 December 2025
··
Merck Stock Forecast and News Roundup for December 24, 2025: MRK Hits a New 52-Week High as Wall Street Reprices 2026 Catalysts

Merck Stock Forecast and News Roundup for December 24, 2025: MRK Hits a New 52-Week High as Wall Street Reprices 2026 Catalysts

Merck shares hit a 12-month high near $106 on December 24, 2025, capping a 30% rally over three months. The surge follows a Trump administration deal requiring Merck to cut prices on drugs like Januvia for Medicaid and direct-to-consumer sales. Analysts cite optimism about Merck’s growth beyond Keytruda’s patent expiration and progress on new drugs.
24 December 2025
··
Edgewise Therapeutics Stock (EWTX) Jumps on EDG-7500 CIRRUS-HCM Update: Dec. 24, 2025 News, Analyst Forecasts, and Key Catalysts

Edgewise Therapeutics Stock (EWTX) Jumps on EDG-7500 CIRRUS-HCM Update: Dec. 24, 2025 News, Analyst Forecasts, and Key Catalysts

Edgewise Therapeutics shares jumped 21% to $26.37 intraday Wednesday after the company reported positive interim safety data for its EDG-7500 therapy in hypertrophic cardiomyopathy. The update showed no clinically meaningful LVEF reductions and no LVEF drops below 50% among 20 patients, with one new-onset atrial fibrillation event disclosed. Over 40 participants have enrolled in Part D of the trial.
24 December 2025
··
Johnson & Johnson Stock Today: JNJ Holds Near $207 on Dec. 24, 2025 as Talc Verdict, Drug-Price Pressure and Q4 Earnings Take Center Stage

Johnson & Johnson Stock Today: JNJ Holds Near $207 on Dec. 24, 2025 as Talc Verdict, Drug-Price Pressure and Q4 Earnings Take Center Stage

Johnson & Johnson traded near $207 per share in thin holiday trading Wednesday, keeping its market value around $500 billion. A Baltimore jury ordered the company to pay over $1.5 billion in a talc cancer case, the largest such verdict to date. J&J said it will appeal. U.S. markets close early at 1 p.m. ET for Christmas Eve.
24 December 2025
···
Citigroup Stock News (NYSE: C) on Dec. 24, 2025: Regulatory Relief, Banamex Progress, and Wall Street Forecasts for 2026

Citigroup Stock News (NYSE: C) on Dec. 24, 2025: Regulatory Relief, Banamex Progress, and Wall Street Forecasts for 2026

Citigroup shares traded around $120.57 to $122 on Dec. 24, 2025, extending gains after regulators eased compliance requirements and analysts cited progress in the bank’s turnaround. The OCC withdrew a 2024 amendment to Citi’s 2020 consent order, though the main order remains. U.S. markets closed early for Christmas Eve, with major indexes near record highs.
24 December 2025
·
ServiceNow Stock (NYSE: NOW) News Today: $7.75B Armis Deal, CEO Contract Extension, and 2026 Analyst Forecasts (Dec. 24, 2025)

ServiceNow Stock (NYSE: NOW) News Today: $7.75B Armis Deal, CEO Contract Extension, and 2026 Analyst Forecasts (Dec. 24, 2025)

ServiceNow shares traded at $152.20 on December 24, down 1.4%, after announcing a $7.75 billion cash deal to acquire cybersecurity firm Armis. The company also extended CEO Bill McDermott’s contract through 2030. The recent 5-for-1 stock split reset share prices. Investors showed caution over the acquisition’s size and ServiceNow’s M&A strategy.
24 December 2025
··
Warner Bros. Discovery (WBD) Series A Stock: Latest News, Deal Battle Updates, and Wall Street Forecasts on Dec. 24, 2025

Warner Bros. Discovery (WBD) Series A Stock: Latest News, Deal Battle Updates, and Wall Street Forecasts on Dec. 24, 2025

Warner Bros. Discovery shares closed at $29.18 on Dec. 24, 2025, amid competing takeover offers. The price sits between Netflix’s $27.75 per share cash-and-stock deal for WBD’s studios and streaming assets and Paramount Skydance’s $30 all-cash hostile bid for the entire company. Paramount Skydance this week added a $40.4 billion personal guarantee from Larry Ellison to back its offer.
24 December 2025
·
Exxon Mobil Stock (XOM) News and Forecast for Dec. 24, 2025: Sakhalin-1 Deadline Extended, Oil Prices Rebound, and Analysts See More Upside

Exxon Mobil Stock (XOM) News and Forecast for Dec. 24, 2025: Sakhalin-1 Deadline Extended, Oil Prices Rebound, and Analysts See More Upside

Exxon Mobil shares traded near $119.62 in thin holiday trading Wednesday after Russia extended the deadline for Exxon to sell its Sakhalin-1 stake to Jan. 1, 2027, according to a Kremlin decree. Crude prices rebounded into year-end, but benchmarks remain on track for their steepest annual drop since 2020. Analyst targets for XOM cluster in the low $130s.
24 December 2025
···
Robinhood Stock (NASDAQ: HOOD) News Today: Holiday Trading, Prediction-Markets Push, and Wall Street Price Targets on Dec. 24, 2025

Robinhood Stock (NASDAQ: HOOD) News Today: Holiday Trading, Prediction-Markets Push, and Wall Street Price Targets on Dec. 24, 2025

Robinhood shares traded near $119–$120 in a thin, shortened Christmas Eve session, following a prior close around $120.25. The stock’s 52-week range spans $29–$154. U.S. markets are set to close at 1 p.m. ET, with light volumes and softer Bitcoin prices weighing on crypto-linked names. Robinhood’s Q3 profit nearly quadrupled to $556 million, beating analyst estimates.
24 December 2025
·
Clearwater Analytics (CWAN) Stock on Dec. 24, 2025: $24.55 Take-Private Deal, Latest Analyst Forecasts, and Key Dates to Watch

Clearwater Analytics (CWAN) Stock on Dec. 24, 2025: $24.55 Take-Private Deal, Latest Analyst Forecasts, and Key Dates to Watch

Clearwater Analytics agreed to be acquired for $24.55 per share in cash, valuing the company at about $8.4 billion including debt. CWAN shares traded at $24.14 on December 24, 2025, reflecting the pending deal. The merger includes a go-shop period through January 23, 2026, allowing Clearwater to seek alternative offers.
24 December 2025
··
AST SpaceMobile (ASTS) Stock Turns Volatile After BlueBird 6 Launch: Dec. 24, 2025 News, Analyst Forecasts, and What’s Next

AST SpaceMobile (ASTS) Stock Turns Volatile After BlueBird 6 Launch: Dec. 24, 2025 News, Analyst Forecasts, and What’s Next

AST SpaceMobile confirmed the successful launch of its BlueBird 6 satellite from India late Tuesday, aiming to deliver space-based 4G/5G broadband to standard smartphones. Shares opened sharply higher Wednesday but fell mid-session amid heavy trading, despite the milestone. The company plans to deploy up to 60 satellites by the end of 2026. U.S. markets closed early for Christmas Eve.
24 December 2025
···
Transocean Stock (NYSE:RIG) News Today: Backlog Wins, Insider Trades, and the Latest Analyst Forecasts on Dec. 24, 2025

Transocean Stock (NYSE:RIG) News Today: Backlog Wins, Insider Trades, and the Latest Analyst Forecasts on Dec. 24, 2025

Transocean shares traded at $4.03 on Dec. 24, 2025, after hitting $4.07 intraday with volume near 6.1 million. The stock moved above a key long-term moving average, fueling talk of a technical breakout. Analysts remain split, with most ratings at “Hold” and targets in the mid-$4 range. Recent contracts added $130 million in Australia and $89 million across Brazil, Norway, and Romania.
24 December 2025
··
1 … 798 799 800 801 802 … 1,356

Stock Market Today

  • GraniteShares 3x AMD ETP (3LAM.PA) Surges 11.3% Pre-Market on Euronext
    March 19, 2026, 11:10 PM EDT. 3LAM.PA, GraniteShares 3x Long AMD Daily ETP, surged 11.30% pre-market to EUR 0.22 on Euronext amid heightened volume of 367,263 shares. The rally was fueled by investor demand for leveraged exposure to AMD, reflecting momentum in AMD derivatives and sector flows. Technical indicators signal a strong trend with an ADX of 37.18 but an oversold RSI of 29.67. The ETP's elevated intraday volatility and low liquidity pose risks including widened spreads and tracking errors, typical for products with daily leveraged resets. Meyka AI rates the instrument a Hold with a grade C+, citing volatility, small market cap of EUR 1.52 million, and reliance on AMD performance. Traders are advised to use caution with position sizes and limit orders, especially amid semiconductor sector fluctuations.
Go toTop